1. Home
  2. WHG vs MDXH Comparison

WHG vs MDXH Comparison

Compare WHG & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

HOLD

Current Price

$18.26

Market Cap

157.9M

Sector

Finance

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.19

Market Cap

167.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHG
MDXH
Founded
1983
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
157.9M
167.8M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
WHG
MDXH
Price
$18.26
$3.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
12.6K
126.0K
Earning Date
10-30-2025
11-12-2025
Dividend Yield
3.29%
N/A
EPS Growth
154.57
N/A
EPS
0.82
N/A
Revenue
$96,243,000.00
$103,069,000.00
Revenue This Year
N/A
$23.34
Revenue Next Year
N/A
$22.98
P/E Ratio
$22.09
N/A
Revenue Growth
4.20
21.68
52 Week Low
$13.49
$1.35
52 Week High
$18.97
$5.33

Technical Indicators

Market Signals
Indicator
WHG
MDXH
Relative Strength Index (RSI) 71.62 34.58
Support Level $16.12 $3.10
Resistance Level $18.47 $3.40
Average True Range (ATR) 0.53 0.17
MACD 0.22 -0.00
Stochastic Oscillator 96.64 16.41

Price Performance

Historical Comparison
WHG
MDXH

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: